A SBIR Phase II contract was awarded to CFD Research Corporation for $1,985,206.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.
To develop an immersive VR environment where clinicians can interact with patients with rare diseases using virtual avatars.